Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.

@article{Seidenfeld1999RelativeEA,
  title={Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.},
  author={Jerome Seidenfeld and David J. Samson and Naomi Aronson and Peter C Albertson and Ahmed M. Bayoumi and Cathy Bennett and Ammani Brown and Anna Garber and Maria Jirom Gere and Vic Hasselblad and Timothy J. Wilt and Karen Ziegler},
  journal={Evidence report/technology assessment},
  year={1999},
  volume={4},
  pages={
          i-x, 1-246, I1-36, passim
        }
}
OBJECTIVES With 184,500 new cases and 39,200 deaths anticipated in 1998, prostate cancer is second only to lung cancer in cancer mortality for men. This report is a systematic review of the evidence from randomized controlled trials on the relative effectiveness of alternative strategies for androgen suppression as treatment of advanced prostate cancer. Three key issues are addressed: (1) the relative effectiveness of the available methods for monotherapy (orchiectomy, luteinizing hormone… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer

International journal of molecular sciences • 2016
View 1 Excerpt

valuation of efficacy of buserelin plus nilutamide in exican Male patients with advanced prostate cancer

F. Velázquez-Macíasa, S. Aguilar-Patiñob, +3 authors N. Contreras-Gonzálezf
2016

Similar Papers

Loading similar papers…